Multidisciplinary: pharmacogenomics

  • Email
  • Help

The European Medicines Agency’s scientific guidelines on pharmacogenomics (PG) help medicine developers prepare marketing authorisation applications for human medicines. 

If you have comments on a document which is open for consultation, use the form for submission of comments on scientific guidelines.

For a complete list of scientific guidelines currently open for consultation, see Public consultations.

PG considerations during drug life cycle

Guidance on technical PG aspects

Therapeutic-specific PG guidance

Procedural guidance

How useful is this page?

Average rating:

 Based on 6 ratings

Add your rating:

See all ratings
1 ratings
0 ratings
0 ratings
1 ratings
4 ratings